Computational and preclinical data support advancement of LTS-201 and LTS-101 programs into clinic later this year Latus founder Beverly Davidson, Ph.D., awarded the ASGCT Outstanding Achievement Award – the Society’s highest honor PHILADELPHIA & BOSTON--(BUSINESS WIRE)--Latus Bio, Inc. (Latus), a company advancing scalable genetic medicines for broad patient populations, today…
Read More
The acquisition brings together the gold standard for continuous ambulatory cough monitoring and lung sound analysis with proven remote spirometry and FeNO capabilities - creating a unique, single-partner endpoint solution for respiratory sponsors. PHILADELPHIA, PA / ACCESS Newswire / April 16, 2026 / Strados Labs, the respiratory endpoint intelligence company, today announced the…
Read More
Presentation details the IND-enabling work for IMGS-203, a potent Stimulator of Interferon Genes (STING) Agonist, for the treatment of Glioblastoma Multiforme (GBM) Houston, Texas, April 15, 2026 /PR Newswire/— ImmunoGenesis, a clinical-stage biotech company developing innovative, science-driven immunotherapies, today announced that it will present a poster at the upcoming American…
Read More
Leveraging AI-Driven Multiomics and Spatial Biology to Unlock the Full Potential of Next-Generation Cytotoxic Dual Checkpoint Inhibitor WALTHAM, Mass. & HOUSTON--(BUSINESS WIRE)--BostonGene, developer of the leading AI foundation model for tumor and immune biology, and ImmunoGenesis, a clinical-stage biotech company developing innovative, science-driven immunotherapies, today announced a strategic partnership to accelerate…
Read More
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Keriton, a market leader in innovative cloud-based software that streamlines breast milk and formula management and supports safe feeding practices, announced today that it has been acquired by Natus Sensory, a global leader in sensory and newborn care solutions. Keriton will become part of Natus Sensory’s Newborn Care portfolio,…
Read More
The SHORE study, in collaboration with Jefferson Health, will assess the feasibility of home-based, continuous monitoring of cough and lung sounds including wheeze and rhonchi following COPD exacerbations. Enrollment started in January. PHILADELPHIA, PA / ACCESS Newswire / January 28, 2026 / Strados Labs, a medical technology company advancing respiratory care through wearable…
Read More
Phase 2b BiRCh Study of Brensocatib in CRSsNP Did Not Meet Primary or Secondary Efficacy Endpoints; Safety Consistent with Previous Studies; Insmed Discontinues CRSsNP Program Company Acquires Phase 2 Ready Monoclonal Antibody for Potential Respiratory and Immunological & Inflammatory Indications BRIDGEWATER, N.J., Dec. 17, 2025 /PRNewswire/ -- Insmed Incorporated (Nasdaq:INSM),…
Read More
Strategic Co-Development Partnership Expands Relationship between Bon Secours Mercy Health and Atalan to Unify Workforce and Patient Experience Analytics PHILADELPHIA, Dec. 10, 2025 (GLOBE NEWSWIRE) -- Atalan, the world’s first Clinical Retention Intelligence (CRI) platform, today announced a strategic partnership with Accrete Health Partners, the venture arm of Bon Secours…
Read More
IMGS-001 is a cytotoxic immune checkpoint inhibitor targeting PD-L1 and PD-L2 and is designed to treat the many “immune-excluded” cancers that are resistant to existing immunotherapies Houston, Texas, Dec. 4, 2025 /PR Newswire/— ImmunoGenesis, a clinical-stage biotech company developing innovative, science-driven immunotherapies, announced today that the company has been awarded…
Read More
LTS-101 is a one-time AAV gene therapy candidate intended to provide durable expression of the TPP1 enzyme in the central nervous system (CNS) of children with CLN2 disease FDA designations underscore the potential of LTS-101 to address a high unmet medical need PHILADELPHIA--(BUSINESS WIRE)--Latus Bio, Inc. (Latus), a biotechnology company…
Read More